Present: Due to an error made during the assembly of Figure [6A](#F1){ref-type="fig"}, the same image panel was inadvertently used for both the RhoA-V14+met (Column 4, Row 1) and Rac1-N17+met (Column 2, Row 2)

Corrected: Correct Figure [6A](#F1){ref-type="fig"} is provided below. The authors sincerely apologize for this error.
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![Rho GTPase inhibitors attenuate metformin effects on the survival of neuroblastoma cells\
(A) Fluorescence images showing the signals of GFP-Rac1, GFP-Cdc42 and GFP-RhoA in SH-SY5Y cells. Cells were infected with adenoviruses expressing GFP-fused dominant--negative Rac1-N17 and Cdc42-N17, and constitutively active RhoA-V14. GFP alone were used as control. After 24 h infection, cells were treated with metformin (10 mM) and further grown for 6 days and photographed. Scale= 200 μm. Number of GFP-containing cells (green) was counted from 10 random fields and plotted.](oncotarget-07-42843-g001){#F1}
